NO984432L - FremgangsmÕte for behandling av migrenesmerte - Google Patents

FremgangsmÕte for behandling av migrenesmerte

Info

Publication number: NO984432L
Authority: NO; Norway
Prior art keywords: procedure; treatment; migraine pain; migraine; pain
Prior art date: 1996-03-25

Application number

NO984432A

Other languages

English (en)

Norwegian (no)

Other versions

NO984432D0 (no

Inventor

Harlan E Shannon

Daniel E Womer

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-25

Filing date

1998-09-23

Publication date

1998-11-24

1998-09-23 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1998-09-23 Publication of NO984432D0 publication Critical patent/NO984432D0/no

1998-11-24 Publication of NO984432L publication Critical patent/NO984432L/no

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

NO984432A 1996-03-25 1998-09-23 FremgangsmÕte for behandling av migrenesmerte NO984432L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1412796P	1996-03-25	1996-03-25
PCT/US1997/004471 WO1997035582A1 (en)	1996-03-25	1997-03-24	Method for treating migraine pain

Publications (2)

Publication Number	Publication Date
NO984432D0 NO984432D0 (no)	1998-09-23
NO984432L true NO984432L (no)	1998-11-24

Family

ID=21763694

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO984432A NO984432L (no)	1996-03-25	1998-09-23	FremgangsmÕte for behandling av migrenesmerte

Country Status (17)

Country	Link
US (1)	US5929070A (zh)
EP (1)	EP0932407A4 (zh)
JP (1)	JP2001508759A (zh)
KR (1)	KR20000004966A (zh)
CN (1)	CN1106196C (zh)
AU (1)	AU721290B2 (zh)
BR (1)	BR9708145A (zh)
CA (1)	CA2250186A1 (zh)
CZ (1)	CZ298398A3 (zh)
EA (1)	EA000769B1 (zh)
IL (1)	IL126063A (zh)
NO (1)	NO984432L (zh)
NZ (1)	NZ332037A (zh)
PL (1)	PL329221A1 (zh)
UA (1)	UA44838C2 (zh)
WO (1)	WO1997035582A1 (zh)
YU (1)	YU42098A (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2248873A1 (en) *	1996-03-25	1997-10-02	Daniel Edward Womer	Method for treating pain
CN1146421C (zh) *	1996-03-25	2004-04-21	伊莱利利公司	治疗疼痛的组合物以及药物在制备所述组合物中的应用
US20070122353A1 (en)	2001-05-24	2007-05-31	Hale Ron L	Drug condensation aerosols and kits
EP1565184A1 (en) *	2002-11-26	2005-08-24	Alexza Molecular Delivery Corporation	Treatment of headache with antipsychotics delivered by inhalation
NZ540207A (en)	2002-11-26	2008-06-30	Alexza Pharmaceuticals Inc	Loxapine (2-chloro-11(4-methyl-1-piperazinyl)dibenz(b, f) (1,4) oxazepine) for the manufacture of a medicament for the treatment of headache
CA2526475A1 (en)	2003-05-21	2004-12-02	Alexza Pharmaceuticals, Inc.	Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
DE112005000641T5 (de)	2004-09-06	2007-09-06	Shasun Chemicals and Drugs Ltd., Chennai	Neues Verfahren zur Herstellung einer pharmazeutisch reinen polymorphen Form I von Olanzapin
US20080216828A1 (en)	2007-03-09	2008-09-11	Alexza Pharmaceuticals, Inc.	Heating unit for use in a drug delivery device
WO2015198350A1 (en)	2014-06-25	2015-12-30	Synergia Bio Sciences Private Limited	A pharmaceutical oil-in-water nano-emulsion
US11400048B2 (en)	2014-06-25	2022-08-02	Synergia Bio Sciences Private Limited	Pharmaceutical oil-in-water nano-emulsion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5229382A (en) *	1990-04-25	1993-07-20	Lilly Industries Limited	2-methyl-thieno-benzodiazepine
CA2110575A1 (en) *	1991-06-21	1993-01-07	John Gerard Ward	Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine
DK206591D0 (da) *	1991-12-23	1991-12-23	Lundbeck & Co As H	Behandling af psykoser
DE69329887T2 (de) *	1992-05-29	2001-05-23	Eli Lilly And Co., Ltd.	Thienobenzodiazepinderivate zur Behandlung von Störungen des Zentralnervensystems
HUT75522A (en) *	1994-03-11	1997-05-28	Lilly Co Eli	Indole-, pyrido-indole-, indolo-quinoline- and benzo-pyrido-indole-derivatives, method for treating 5ht2b receptor related conditions, pharmaceutical compositions containing them
US5457101A (en) *	1994-06-03	1995-10-10	Eli Lilly And Company	Thieno[1,5]benzoidiazepine use
EG23659A (en) *	1995-03-24	2007-03-26	Lilly Co Eli	Process and crystal forms of methyl-thieno-benzodiazepine

1997
- 1997-03-24 IL IL12606397A patent/IL126063A/en not_active IP Right Cessation
- 1997-03-24 CN CN97194950A patent/CN1106196C/zh not_active Expired - Fee Related
- 1997-03-24 AU AU25845/97A patent/AU721290B2/en not_active Ceased
- 1997-03-24 US US08/823,457 patent/US5929070A/en not_active Expired - Fee Related
- 1997-03-24 PL PL97329221A patent/PL329221A1/xx unknown
- 1997-03-24 EA EA199800864A patent/EA000769B1/ru not_active IP Right Cessation
- 1997-03-24 KR KR1019980707570A patent/KR20000004966A/ko not_active Application Discontinuation
- 1997-03-24 NZ NZ332037A patent/NZ332037A/xx unknown
- 1997-03-24 JP JP53449197A patent/JP2001508759A/ja not_active Ceased
- 1997-03-24 CZ CZ982983A patent/CZ298398A3/cs unknown
- 1997-03-24 EP EP97917556A patent/EP0932407A4/en not_active Withdrawn
- 1997-03-24 WO PCT/US1997/004471 patent/WO1997035582A1/en not_active Application Discontinuation
- 1997-03-24 BR BR9708145A patent/BR9708145A/pt not_active Application Discontinuation
- 1997-03-24 UA UA98095009A patent/UA44838C2/uk unknown
- 1997-03-24 CA CA002250186A patent/CA2250186A1/en not_active Abandoned
1998
- 1998-09-23 NO NO984432A patent/NO984432L/no not_active Application Discontinuation
- 1998-09-25 YU YU42098A patent/YU42098A/sh unknown

Also Published As

Publication number	Publication date
EP0932407A4 (en)	2002-04-24
BR9708145A (pt)	1999-07-27
EP0932407A1 (en)	1999-08-04
AU721290B2 (en)	2000-06-29
NO984432D0 (no)	1998-09-23
CA2250186A1 (en)	1997-10-02
CN1219876A (zh)	1999-06-16
EA199800864A1 (ru)	1999-02-25
KR20000004966A (ko)	2000-01-25
UA44838C2 (uk)	2002-03-15
EA000769B1 (ru)	2000-04-24
US5929070A (en)	1999-07-27
WO1997035582A1 (en)	1997-10-02
NZ332037A (en)	2001-01-26
CN1106196C (zh)	2003-04-23
JP2001508759A (ja)	2001-07-03
IL126063A (en)	2002-04-21
AU2584597A (en)	1997-10-17
PL329221A1 (en)	1999-03-15
YU42098A (sh)	1999-09-27
CZ298398A3 (cs)	1999-06-16
IL126063A0 (en)	1999-05-09

Legal Events

Date	Code	Title	Description
2005-10-17	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO984431D0 (no)	1998-09-23	FremgangsmÕte for behandling av smerte
NO991381D0 (no)	1999-03-22	Kombinasjonsterapi for behandling av psykoser
NO991955D0 (no)	1999-04-23	FremgangsmÕte for behandling av hydrokarboner
NO982172D0 (no)	1998-05-13	Anvendelse av epinastin for behandling av smerter
NO983284D0 (no)	1998-07-16	Antikoagolante midler egnet i behandling av trombose
NO20005864D0 (no)	2000-11-20	Quinasoler til behandling av hjernesvulst
DE69739303D1 (de)	2009-04-23	Vorrichtung zur thermischen behandlung von gewebe
NO974554L (no)	1998-07-15	FremgangsmÕte for behandling av en underjordisk formasjon
NO20005884L (no)	2001-01-24	Kombinasjonsterapi for behandling av bipolare forstyrrelser
DE69711311D1 (de)	2002-05-02	Vorrichtung zur thermischen Behandlung von Gewebe
NO20003042L (no)	2000-06-14	FremgangsmÕte for profylaktisk behandling av mastitt
NO991459L (no)	1999-03-25	Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
DE69620691D1 (de)	2002-05-23	Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
ATE347372T1 (de)	2006-12-15	Vakzine zur behandlung von mycosen
NO984446D0 (no)	1998-09-24	FremgangsmÕte for behandling av smerte
NO984432D0 (no)	1998-09-23	FremgangsmÕte for behandling av migrenesmerte
NO994258L (no)	1999-11-02	Anvendelse av levobupivakain for behandling av ansiktsmigrene
NO991734D0 (no)	1999-04-13	Pyrazolinoner for behandling av potensforstyrrelser
NO982582D0 (no)	1998-06-05	FremgangsmÕte for behandling av smerte
NO984189D0 (no)	1998-09-11	Fremgangsmåte for behandling av bipolar forstyrrelse
NO973366D0 (no)	1997-07-21	Fremgangsmåte for behandling av multippel sklerose
NO982562D0 (no)	1998-06-04	Sammensetning for behandling av smerte
NO20003481D0 (no)	2000-07-06	FremgangsmÕte for behandling av COPD
NO991158L (no)	1999-03-10	FremgangsmÕte for behandling av amyotrofisk lateralsklerose
NO20002481D0 (no)	2000-05-12	Kombinasjonsterapi for behandling av AIDS